YD Bio Limited Ordinary Shares Receivables

YD Bio Limited Ordinary Shares (YDES) currently reports a receivables of $710K as of December 2025. That compares with $260K in the prior-year period — up 171.0% year over year. Use the charts on this page to explore YD Bio Limited Ordinary Shares's receivables history and peer comparisons.

YD Bio Limited Ordinary Shares's receivables increased from $260K to $710K — a 171.0% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

YD Bio Limited Ordinary Shares reported $710K in receivables as of December 2025. That compares with $260K in the prior-year period — up 171.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $710K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for YD Bio Limited Ordinary Shares, and consider following YDES for alerts when major investors trade the stock.

YD Bio Limited Ordinary Shares is classified in the Healthcare sector. On receivables, it currently shows $710K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing YDES with unrelated industries.